Evaluation of the efficacy of HEMO2life®, a marine OXYgen carrier for Organ Preservation (OxyOp2) in renal transplantation: study protocol for a multicenter randomized trial

Evaluation of the efficacy of HEMO2life®, a marine OXYgen carrier for Organ Preservation (OxyOp2) in renal transplantation: study protocol for a multicenter randomized trial

Abstract Background Preventing ischemia‒reperfusion injury (IRI) is a major issue in kidney transplantation, particularly for transplant recipients receiving a kidney from extended criteria donors (ECD). The main consequence of IRI is delayed graft function (DGF). Hypoxia is one of the key factors i...

Full description

Bibliographic Details
Main Authors: Yannick Le Meur, Emmanuel Nowak, Benoit Barrou, Antoine Thierry, Lionel Badet, Matthias Buchler, Jean-Philippe Rerolle, Leonard Golbin, Agnès Duveau, Jacques Dantal, Pierre Merville, Nassim Kamar, Leïla Demini, Franck Zal
Format: Article
Language:English
Published: BMC 2023-05-01
Series:Trials
Subjects:
HEMO2life®
Clinical trial
Delayed Graft Function (DGF)
Transplantation
Ischemia–Reperfusion Injury (IRI)
Kidney IRI
Online Access:https://doi.org/10.1186/s13063-023-07302-3

Internet

https://doi.org/10.1186/s13063-023-07302-3

Similar Items